Biopharmaceutical purification agreement

Published on: 

Distribution and collaboration agreements in biopharmaceutical purification

GE Healthcare and Parker domnick hunter, a division of Parker Hannifin, have entered into an exclusive agreement for the supply and distribution of products for biopharmaceutical purification. GE Healthcare will have exclusive global rights to market a new range of microfiltration cartridges and disposable filters manufactured by Parker domnick hunter under the terms of the agreement.The new line of disposable filters for liquid filtration applications in biopharmaceutical manufacture will be marketed by GE Healthcare's global sales and marketing organization under the ULTA brand. The products are set to increase the range of technologies available for the purification of vaccines, antibodies and other biomolecules.

"We developed an outstanding line of cartridge filters with an eye to making significant developments in roads into the pharmaceutical market, expanding on our past successes in this area." said Jeff Porter, MD, Process Division, Europe at Parker domnick hunter. "We are very excited about the prospects of this agreement, which enables us to bring our advanced purification technologies to the biopharmaceutical production industry."

Parker domnick hunter will continue to market its own brand of air and gas filters to the biopharmaceutical industry. The two companies will collaborate in the development of new technologies for protein purification, under a separate joint technology development agreement, in separation and purification techniques, membrane production manufacturing and market insights.